GlassScriptPhysician profile
Ritesh D Patel
NPI 1548371982
$12,866.21
in general payments reported to CMS, 2019-2025
60 companies · $1,626 in 2025
The $1,626 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,063 · 2020: $1,946 · 2021: $2,234 · 2022: $1,928 · 2023: $1,282 · 2024: $1,787 · 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,695.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,869.04 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,792.80 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,374.21 | 2019-2025 | Jardiance, Synjardy |
| Janssen Pharmaceuticals, INC | $1,083.86 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $819.47 | 2019-2025 | Ozempic, Rybelsus, Tresiba |
| Amarin Pharma, INC. | $624.06 | 2019-2023 | |
| Amgen INC. | $592.93 | 2019-2025 | Evenity, Repatha, Prolia |
| Glaxosmithkline, LLC. | $532.45 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $511.48 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $487.90 | 2021-2025 | |
| Abbvie INC. | $455.19 | 2019-2025 | |
| Preventric Diagnostics, INC. | $212.53 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $211.21 | 2019-2025 | Xifaxan, Trulance |
| Corcept Therapeutics | $204.33 | 2024-2025 | Korlym |
| Horizon Therapeutics Plc | $140.56 | 2020-2022 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.